OBJECTIVE: To determine the prevalence of the use of prenatal corticosteroids in women who delivered prematurely in 3 Latin American counties and to evaluate the maternal characteristics associated with use. METHODS: A multicenter, prospective, descriptive study was conducted in 4 hospitals in Ecuador, 5 in Uruguay, and 3 in El Salvador between 2004 and 2008. Women who had delivered between 24 and 34 weeks of pregnancy responded to a questionnaire assessing sociodemographic characteristics, obstetric history, prenatal care, women's attitudes to health services and knowledge of preterm risk factors, prenatal corticosteroid administration, and characteristics of the delivery and neonate. The association between the prenatal corticosteroid use and the study variables was evaluated through a logistic regression analysis based on a hierarchical model. RESULTS: A total of 1062 women who had a preterm birth were included in the study. Prenatal corticosteroid use was 34.8% (95% CI, 29.9%-39.9%) in Ecuador, 54.6% (95% CI, 49.6%-59.6%) in El Salvador, and 71.0% (95% CI, 65.3%-76.2%) in Uruguay. Hospital admission-to-delivery time was associated with the use of prenatal corticosteroids in all 3 countries. CONCLUSION: The study revealed a varied pattern of use of prenatal corticosteroids across the 3 countries, and a diversity of influencing factors.
OBJECTIVE: To determine the prevalence of the use of prenatal corticosteroids in women who delivered prematurely in 3 Latin American counties and to evaluate the maternal characteristics associated with use. METHODS: A multicenter, prospective, descriptive study was conducted in 4 hospitals in Ecuador, 5 in Uruguay, and 3 in El Salvador between 2004 and 2008. Women who had delivered between 24 and 34 weeks of pregnancy responded to a questionnaire assessing sociodemographic characteristics, obstetric history, prenatal care, women's attitudes to health services and knowledge of preterm risk factors, prenatal corticosteroid administration, and characteristics of the delivery and neonate. The association between the prenatal corticosteroid use and the study variables was evaluated through a logistic regression analysis based on a hierarchical model. RESULTS: A total of 1062 women who had a preterm birth were included in the study. Prenatal corticosteroid use was 34.8% (95% CI, 29.9%-39.9%) in Ecuador, 54.6% (95% CI, 49.6%-59.6%) in El Salvador, and 71.0% (95% CI, 65.3%-76.2%) in Uruguay. Hospital admission-to-delivery time was associated with the use of prenatal corticosteroids in all 3 countries. CONCLUSION: The study revealed a varied pattern of use of prenatal corticosteroids across the 3 countries, and a diversity of influencing factors.
Authors: Mercedes Colomar; María Belizán; María Luisa Cafferata; Ana Labandera; Giselle Tomasso; Fernando Althabe; José M Belizán Journal: Ginecol Obstet Mex Date: 2004-09
Authors: Fernando Althabe; José M Belizán; Elizabeth M McClure; Jennifer Hemingway-Foday; Mabel Berrueta; Agustina Mazzoni; Alvaro Ciganda; Shivaprasad S Goudar; Bhalachandra S Kodkany; Niranjana S Mahantshetti; Sangappa M Dhaded; Geetanjali M Katageri; Mrityunjay C Metgud; Anjali M Joshi; Mrutyunjaya B Bellad; Narayan V Honnungar; Richard J Derman; Sarah Saleem; Omrana Pasha; Sumera Ali; Farid Hasnain; Robert L Goldenberg; Fabian Esamai; Paul Nyongesa; Silas Ayunga; Edward A Liechty; Ana L Garces; Lester Figueroa; K Michael Hambidge; Nancy F Krebs; Archana Patel; Anjali Bhandarkar; Manjushri Waikar; Patricia L Hibberd; Elwyn Chomba; Waldemar A Carlo; Angel Mwiche; Melody Chiwila; Albert Manasyan; Sayury Pineda; Sreelatha Meleth; Vanessa Thorsten; Kristen Stolka; Dennis D Wallace; Marion Koso-Thomas; Alan H Jobe; Pierre M Buekens Journal: Lancet Date: 2014-10-15 Impact factor: 79.321
Authors: Grace Liu; Joel Segrè; A Gülmezoglu; Matthews Mathai; Jeffrey M Smith; Jorge Hermida; Aline Simen-Kapeu; Pierre Barker; Mercy Jere; Edward Moses; Sarah G Moxon; Kim E Dickson; Joy E Lawn; Fernando Althabe Journal: BMC Pregnancy Childbirth Date: 2015-09-11 Impact factor: 3.007
Authors: Stanley Mwita; Eveline Konje; Benjamin Kamala; Angelina Izina; Semvua Kilonzo; Andrew Kigombola; Karol J Marwa; Mary Jande; Deborah Dewey Journal: PLoS One Date: 2021-07-22 Impact factor: 3.240
Authors: Fernando Althabe; José M Belizán; Agustina Mazzoni; Mabel Berrueta; Jay Hemingway-Foday; Marion Koso-Thomas; Elizabeth McClure; Elwyn Chomba; Ana Garces; Shivaprasad Goudar; Bhalchandra Kodkany; Sarah Saleem; Omrana Pasha; Archana Patel; Fabian Esamai; Waldemar A Carlo; Nancy F Krebs; Richard J Derman; Robert L Goldenberg; Patricia Hibberd; Edward A Liechty; Linda L Wright; Eduardo F Bergel; Alan H Jobe; Pierre Buekens Journal: Reprod Health Date: 2012-09-19 Impact factor: 3.223
Authors: Alicia Aleman; Maria L Cafferata; Luz Gibbons; Fernando Althabe; Jose Ortiz; Xochitl Sandoval; Nicolás Padilla-Raygoza; José M Belizán Journal: Reprod Health Date: 2013-01-29 Impact factor: 3.223